1. Home
  2. HTLD vs AVLN Comparison

HTLD vs AVLN Comparison

Compare HTLD & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$12.25

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$35.69

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTLD
AVLN
Founded
1978
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
HTLD
AVLN
Price
$12.25
$35.69
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
674.8K
175.5K
Earning Date
04-23-2026
N/A
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$805,709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.36
N/A
P/E Ratio
$174.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$24.90
52 Week High
$16.64
$40.17

Technical Indicators

Market Signals
Indicator
HTLD
AVLN
Relative Strength Index (RSI) 43.18 52.92
Support Level $11.75 $34.22
Resistance Level $13.09 $40.08
Average True Range (ATR) 0.44 1.99
MACD 0.06 -0.29
Stochastic Oscillator 39.11 35.16

Price Performance

Historical Comparison
HTLD
AVLN

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: